Bonesupport raised sales guidance for the year 2024. Given this growth trend and the recent U.S. regulatory approval in open fractures, the company is raising the company's 2024 guidance. The company expecting a sales increase of over 50% in constant currency versus previous year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
275.2 SEK | +0.22% |
|
-3.44% | +46.23% |
07-11 | Bonesupport Raises Sales Guidance for the Year 2024 | CI |
07-11 | Transcript : Bonesupport Holding AB, Q2 2024 Earnings Call, Jul 11, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+46.23% | 1.7B | |
+7.46% | 100B | |
+11.97% | 42.34B | |
-11.32% | 32.76B | |
+79.34% | 29.46B | |
-12.28% | 16.31B | |
+3.58% | 14.39B | |
-1.90% | 12.23B | |
+178.17% | 10.47B | |
+1.80% | 8.97B |
- Stock Market
- Equities
- BONEX Stock
- News Bonesupport Holding AB
- Bonesupport Raises Sales Guidance for the Year 2024